drugset / Trial / NCT00708903

Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)

NCT00708903

Phase 1 Completed 60 enrolled Puma Biotechnology, Inc.
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine whether HKI-272 affects the rhythms of the heart (cardiac repolarization).

Timeline

Start
2008-05
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Moxifloxacin Small molecule
Subject Neratinib Small molecule

Indications